SOLASIA PHARMA K K: Confirmation letter
SOLASIA PHARMA K K: Quarterly Report - 17th Quarter 1st Quarter (2024/01/01 - 2024/03/31)
SOLASIA PHARMA K K: Summary of financial results for the 1st quarter of the fiscal year ending 2024/12 [IFRS] (consolidated)
SOLASIA PHARMA K K: Business Status of Product Development Products, etc. (1st quarter of the fiscal year ending 2024/12)
SOLASIA PHARMA K K: Pipeline Products Business Overview (1st quarter of the fiscal year ending December 31, 2024)
SOLASIA PHARMA K K: Consolidated financial results for the first three months of the fiscal year ending December 31, 2024 (based on IFRS)
SOLASIA PHARMA K K: Notice regarding completion of early redemption of unsecured ordinary corporate bonds
SOLASIA PHARMA K K: Notice regarding the monthly exercise status of the 14th Stock Acquisition Rights with Exercise Price Amendment Clauses
SOLASIA PHARMA K K: Change Report
SOLASIA PHARMA K K: Change Report
SOLASIA PHARMA K K: 14th Notice Concerning Mass Exercise of Stock Acquisition Rights with Exercise Price Amendment Clauses
Solasia Pharma: Change Report
Solasia Pharma: Notice Concerning Mass Exercise of the 14th Stock Acquisition Rights with Exercise Price Amendment Clauses
Solasia Pharma: Change Report
Solasia Pharma: Change Report
Solasia Pharma: Notice Concerning the Monthly Exercise Status of the 14th Stock Acquisition Rights with Exercise Price Amendment Clauses
Solasia Pharma KK: Matters relating to business plans and growth potential
Solasia Pharma: Change Report
Solasia Pharma: Extraordinary Report
Solasia Pharma: Internal Control Report - Term 16 (2023/01/01 - 2023/12/31)
No Data